← Volver al ranking

Thumbnails similares a Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024?

20 vecinos (thumb_512) · 53 views · ERN ReCONNET · —

★Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024?

ERN ReCONNET

@ernreconnet

53—
5IgG4-related disease (IgG4-RD): update on diagnosis and treatments in 2025

ERN ReCONNET

@ernreconnet

1.3K—76
17Diagnosis and management of peripheral neurological manifestations in Sjögren’s disease

ERN ReCONNET

@ernreconnet

748—73
8Recent advances in the treatment of inflammatory myopathies

ERN ReCONNET

@ernreconnet

618—74
19Steroids in Relapsing Polychondritis

ERN ReCONNET

@ernreconnet

474—73
15How to find hidden Antiphospholipid Syndrome (APS)

ERN ReCONNET

@ernreconnet

471—73
4CAR-T Therapy in Systemic Lupus Erythematosus (SLE): Explained to the Patient

ERN ReCONNET

@ernreconnet

441—76
1What is the added value of triple therapy in lupus nephritis?

ERN ReCONNET

@ernreconnet

438—80
9Update on B cell targeting therapies in IgG4-related disease

ERN ReCONNET

@ernreconnet

375—74
3How to explain the antiphospholipid profile to my patients?

ERN ReCONNET

@ernreconnet

300—77
18Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025?

ERN ReCONNET

@ernreconnet

285—73
7Exercise as a non-pharmacological treatment adjunct to pharmacotherapy in systemic sclerosis.

ERN ReCONNET

@ernreconnet

222—74
16Exercise in adult idiopathic inflammatory myopathies (IIMs)

ERN ReCONNET

@ernreconnet

188—73
11Imaging in Relapsing Polychondritis (RP)

ERN ReCONNET

@ernreconnet

171—74
6Everything you always wanted to know about Ehlers-Danlos Syndromes (EDS) – Part two

ERN ReCONNET

@ernreconnet

151—75
20Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering

ERN ReCONNET

@ernreconnet

137—73
12Vaccination in undifferentiated connective tissue disease (UCTD)

ERN ReCONNET

@ernreconnet

103—74
2Osteoporosis in rare and complex connective tissue diseases

ERN ReCONNET

@ernreconnet

96—78
13Obstetric manifestations in past and present antiphospholipid syndrome (APS) classification criteria

ERN ReCONNET

@ernreconnet

94—73
10Multidisciplinary diagnosis and team treatment in Idiopathic Inflammatory Myopathies

ERN ReCONNET

@ernreconnet

64—74
14“Doctor, can you ask me…?” for connective tissue diseases patients

ERN ReCONNET

@ernreconnet

46—73